doxazosin and cyclic gmp

doxazosin has been researched along with cyclic gmp in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (16.67)18.2507
2000's3 (50.00)29.6817
2010's2 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kakihana, M; Ohtsuka, S; Sugishita, Y; Watanabe, H1
Casado, S; de Andrés, R; Fortes, J; García-Colis, E; Gomez, J; López-Blaya, A; López-Farré, A; Rico, L; Rodriguez-Feo, JA1
Azadzoi, KM; Babayan, RK; Kozlowski, R; Siroky, MB1
Azadzoi, KM1
Andric, SA; Janjic, MM; Kostic, TS; Stojkov, NJ1
Andric, SA; Baburski, AZ; Bjelic, MM; Drljaca, DM; Janjic, MM; Kostic, TS; Mihajlovic, AI; Sokanovic, SJ; Stojkov, NJ1

Trials

1 trial(s) available for doxazosin and cyclic gmp

ArticleYear
Randomized, double-blind, placebo-controlled study of carvedilol on the prevention of nitrate tolerance in patients with chronic heart failure.
    Journal of the American College of Cardiology, 1998, Volume: 32, Issue:5

    Topics: Adrenergic Antagonists; Aged; Blood Flow Velocity; Blood Platelets; Blood Pressure; Carbazoles; Carvedilol; Chronic Disease; Cyclic GMP; Double-Blind Method; Doxazosin; Drug Hypersensitivity; Drug Therapy, Combination; Female; Follow-Up Studies; Forearm; Heart Failure; Heart Rate; Humans; Male; Metoprolol; Middle Aged; Nitroglycerin; Propanolamines; Vasodilator Agents

1998

Other Studies

5 other study(ies) available for doxazosin and cyclic gmp

ArticleYear
Reduction of the soluble cyclic GMP vasorelaxing system in the vascular wall of stroke-prone spontaneously hypertensive rats: effect of the alpha1 -receptor blocker doxazosin.
    Journal of hypertension, 2002, Volume: 20, Issue:3

    Topics: Acetylcholine; Adrenergic alpha-Antagonists; Animals; Aorta; Cyclic GMP; Doxazosin; Endothelium, Vascular; Genetic Predisposition to Disease; Guanylate Cyclase; Hypertension; In Vitro Techniques; Isoenzymes; Male; Muscle, Smooth, Vascular; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Nitroprusside; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Solubility; Stroke; Vasodilation; Vasodilator Agents

2002
Chronic ischemia increases prostatic smooth muscle contraction in the rabbit.
    The Journal of urology, 2003, Volume: 170, Issue:2 Pt 1

    Topics: Adrenergic alpha-Antagonists; Animals; Arginine; Arteriosclerosis; Blood Flow Velocity; Cyclic GMP; Doxazosin; Electric Stimulation; Iliac Artery; In Vitro Techniques; Ischemia; Laser-Doppler Flowmetry; Male; Muscle Contraction; Muscle, Smooth; Nitric Oxide; Phosphodiesterase Inhibitors; Piperazines; Prostate; Purines; Rabbits; Sildenafil Citrate; Sulfones

2003
Editorial comment on: Immunohistochemical distribution of cyclic GMP-dependent protein kinase-1 in human prostate tissue.
    European urology, 2007, Volume: 52, Issue:2

    Topics: Actins; Adrenergic alpha-Antagonists; Aged; Animals; Blotting, Western; Cyclic GMP; Cyclic GMP-Dependent Protein Kinases; Doxazosin; Humans; Immunohistochemistry; Male; Middle Aged; Phosphodiesterase Inhibitors; Piperazines; Prostate; Prostatic Hyperplasia; Prostatic Neoplasms; Purines; Sildenafil Citrate; Sulfones

2007
Orally applied doxazosin disturbed testosterone homeostasis and changed the transcriptional profile of steroidogenic machinery, cAMP/cGMP signalling and adrenergic receptors in Leydig cells of adult rats.
    Andrology, 2013, Volume: 1, Issue:2

    Topics: Adrenergic alpha-1 Receptor Antagonists; Androgens; Animals; Cells, Cultured; Cyclic AMP; Cyclic AMP-Dependent Protein Kinase RIIbeta Subunit; Cyclic GMP; Doxazosin; Guanylate Cyclase; Homeostasis; Hypertension; Leydig Cells; Luteinizing Hormone; Male; Organ Culture Techniques; Prostatic Hyperplasia; Prostatic Neoplasms; Rats; Receptors, Adrenergic; Receptors, Adrenergic, alpha-1; Signal Transduction; Steroids; Testosterone; Transcription, Genetic

2013
In vivo blockade of α1-adrenergic receptors mitigates stress-disturbed cAMP and cGMP signaling in Leydig cells.
    Molecular human reproduction, 2014, Volume: 20, Issue:1

    Topics: Adrenergic alpha-1 Receptor Antagonists; AMP-Activated Protein Kinases; Animals; Corticosterone; Cyclic AMP; Cyclic GMP; Cyclic GMP-Dependent Protein Kinase Type I; Cyclic Nucleotide Phosphodiesterases, Type 4; Doxazosin; Epinephrine; Guanylate Cyclase; Insulin; Leydig Cells; Luteinizing Hormone; Male; Nitric Oxide Synthase Type III; Proteins; Rats; Rats, Wistar; Receptors, Adrenergic, alpha-1; Receptors, Cytoplasmic and Nuclear; Signal Transduction; Soluble Guanylyl Cyclase; Stress, Physiological; Testosterone

2014